<DOC>
	<DOC>NCT00165711</DOC>
	<brief_summary>Patients who fit the inclusion criteria are admitted into the study. They are given 3 IV injection of MBL in the first week and one tablet three times a day for 16 weeks.</brief_summary>
	<brief_title>The Role of Methycobalamin in Early Dementia Patients With Vitamin B12 Deficiency and Hyperhomocysteinaemia.</brief_title>
	<detailed_description />
	<mesh_term>Dementia</mesh_term>
	<mesh_term>Vitamin B 12 Deficiency</mesh_term>
	<criteria>Inclusion: Patients with Dementia Serum B12 &lt; 200 pmol/l Serum Homocysteine level &gt; 11.0 micro mol/L Exclusion: Significant communication problems deafness, dysarthria, dysphasia etc. unstable DM or hypertension alcohol abuse coexisting diseases which may affect cognition e.g. cognitive cardiac failure, respiratory failure folate &lt; 10 g/dl haemoglobin concentration &lt; 10g/d abnormal thyroid function test or VDRL</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2005</verification_date>
</DOC>